Becton Dickinson & Co. (BD) is recalling approximately 18,500 BD Phoenix NMIC-306 and Yeast ID diagnostic panels because some units were contaminated with drugs or incorrect substances during manufacturing. These panels are used by healthcare facilities to identify infections and determine which antibiotics or treatments will work best for a patient. If these defective panels are used, they may provide incorrect results, causing a doctor to prescribe the wrong medicine, an inadequate dose, or no treatment at all. The Yeast ID panels specifically may trigger a 'Fluorescent interference' error and cancel the test entirely due to the presence of an misplaced substance called Esculin.
The contamination can lead to incorrect or delayed lab results, which may result in patients receiving the wrong antibiotic treatment or no treatment for serious infections. In the case of the Yeast ID panels, the system may automatically abort the test, causing critical delays in patient diagnosis and care.
Contact healthcare provider or manufacturer
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.